Martha Lilac Ketisha Antoine M, Xu Y. Sodium-glucose cotransporter-2 inhibitors: current knowledge on the use of canagliflozin, dapagliflozin and empagliflozin in the treatment of type 2 diabetes mellitus. IJM [Internet]. 2020 Mar. 6 [cited 2024 Dec. 5];8(1):8-12. Available from: https://sciencepubco.com/index.php/IJM/article/view/30308